If you've ever invested in stocks or followed market news, you might wonder why a company's shares can suddenly jump. We'll explore how a recent biotech acquisition caused a massive stock surge, and what it means for future medical breakthroughs.
APLS stock recently surged over 140% in a single day, making headlines and sparking interest in biotech acquisitions.
This dramatic jump occurred after AstraZeneca announced its intent to acquire APLISens Inc. (APLS), a clinical-stage biopharmaceutical company.